Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 401

1.

Effects of tamoxifen on benign breast disease in women at high risk for breast cancer.

Tan-Chiu E, Wang J, Costantino JP, Paik S, Butch C, Wickerham DL, Fisher B, Wolmark N.

J Natl Cancer Inst. 2003 Feb 19;95(4):302-7.

PMID:
12591986
[PubMed - indexed for MEDLINE]
Free Article
2.

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.

Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N.

J Natl Cancer Inst. 2005 Nov 16;97(22):1652-62.

PMID:
16288118
[PubMed - indexed for MEDLINE]
Free Article
3.

Tamoxifen for the prevention of breast cancer: late results of the Italian Randomized Tamoxifen Prevention Trial among women with hysterectomy.

Veronesi U, Maisonneuve P, Rotmensz N, Bonanni B, Boyle P, Viale G, Costa A, Sacchini V, Travaglini R, D'Aiuto G, Oliviero P, Lovison F, Gucciardo G, del Turco MR, Muraca MG, Pizzichetta MA, Conforti S, Decensi A; Italian Tamoxifen Study Group.

J Natl Cancer Inst. 2007 May 2;99(9):727-37.

PMID:
17470740
[PubMed - indexed for MEDLINE]
Free Article
4.

Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial.

Vogel VG, Costantino JP, Wickerham DL, Cronin WM, Cecchini RS, Atkins JN, Bevers TB, Fehrenbacher L, Pajon ER Jr, Wade JL 3rd, Robidoux A, Margolese RG, James J, Lippman SM, Runowicz CD, Ganz PA, Reis SE, McCaskill-Stevens W, Ford LG, Jordan VC, Wolmark N; National Surgical Adjuvant Breast and Bowel Project (NSABP).

JAMA. 2006 Jun 21;295(23):2727-41. Epub 2006 Jun 5. Erratum in: JAMA. 2006 Dec 27;296(24):2926. JAMA. 2007 Sep 5;298(9):973.

PMID:
16754727
[PubMed - indexed for MEDLINE]
5.

Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).

Beattie MS, Costantino JP, Cummings SR, Wickerham DL, Vogel VG, Dowsett M, Folkerd EJ, Willett WC, Wolmark N, Hankinson SE.

J Natl Cancer Inst. 2006 Jan 18;98(2):110-5.

PMID:
16418513
[PubMed - indexed for MEDLINE]
Free Article
6.

Estimation of tamoxifen's efficacy for preventing the formation and growth of breast tumors.

Radmacher MD, Simon R.

J Natl Cancer Inst. 2000 Jan 5;92(1):48-53.

PMID:
10620633
[PubMed - indexed for MEDLINE]
Free Article
7.

Estimates of the number of US women who could benefit from tamoxifen for breast cancer chemoprevention.

Freedman AN, Graubard BI, Rao SR, McCaskill-Stevens W, Ballard-Barbash R, Gail MH.

J Natl Cancer Inst. 2003 Apr 2;95(7):526-32.

PMID:
12671020
[PubMed - indexed for MEDLINE]
Free Article
8.

Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial.

Powles TJ, Ashley S, Tidy A, Smith IE, Dowsett M.

J Natl Cancer Inst. 2007 Feb 21;99(4):283-90.

PMID:
17312305
[PubMed - indexed for MEDLINE]
Free Article
9.

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial.

Powles T, Eeles R, Ashley S, Easton D, Chang J, Dowsett M, Tidy A, Viggers J, Davey J.

Lancet. 1998 Jul 11;352(9122):98-101.

PMID:
9672274
[PubMed - indexed for MEDLINE]
10.

Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer.

Dignam JJ, Wieand K, Johnson KA, Fisher B, Xu L, Mamounas EP.

J Natl Cancer Inst. 2003 Oct 1;95(19):1467-76.

PMID:
14519753
[PubMed - indexed for MEDLINE]
Free Article
11.

Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial.

Chalas E, Costantino JP, Wickerham DL, Wolmark N, Lewis GC, Bergman C, Runowicz CD.

Am J Obstet Gynecol. 2005 Apr;192(4):1230-7; discussion 1237-9.

PMID:
15846210
[PubMed - indexed for MEDLINE]
12.

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

King MC, Wieand S, Hale K, Lee M, Walsh T, Owens K, Tait J, Ford L, Dunn BK, Costantino J, Wickerham L, Wolmark N, Fisher B; National Surgical Adjuvant Breast and Bowel Project.

JAMA. 2001 Nov 14;286(18):2251-6.

PMID:
11710890
[PubMed - indexed for MEDLINE]
13.

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study.

Bertelsen L, Bernstein L, Olsen JH, Mellemkjaer L, Haile RW, Lynch CF, Malone KE, Anton-Culver H, Christensen J, Langholz B, Thomas DC, Begg CB, Capanu M, Ejlertsen B, Stovall M, Boice JD Jr, Shore RE; Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group, Bernstein JL.

J Natl Cancer Inst. 2008 Jan 2;100(1):32-40. Epub 2007 Dec 25.

PMID:
18159070
[PubMed - indexed for MEDLINE]
Free Article
14.

Tamoxifen and breast density in women at increased risk of breast cancer.

Cuzick J, Warwick J, Pinney E, Warren RM, Duffy SW.

J Natl Cancer Inst. 2004 Apr 21;96(8):621-8.

PMID:
15100340
[PubMed - indexed for MEDLINE]
Free Article
15.

Cardiovascular effects of tamoxifen in women with and without heart disease: breast cancer prevention trial. National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial Investigators.

Reis SE, Costantino JP, Wickerham DL, Tan-Chiu E, Wang J, Kavanah M.

J Natl Cancer Inst. 2001 Jan 3;93(1):16-21.

PMID:
11136837
[PubMed - indexed for MEDLINE]
Free Article
16.

The role of tamoxifen in breast cancer prevention: issues sparked by the NSABP Breast Cancer Prevention Trial (P-1).

Wolmark N, Dunn BK.

Ann N Y Acad Sci. 2001 Dec;949:99-108.

PMID:
11795386
[PubMed - indexed for MEDLINE]
17.

Contralateral breast cancer and thromboembolic events in African American women treated with tamoxifen.

McCaskill-Stevens W, Wilson J, Bryant J, Mamounas E, Garvey L, James J, Cronin W, Wickerham DL.

J Natl Cancer Inst. 2004 Dec 1;96(23):1762-9. Erratum in: J Natl Cancer Inst. 2005 Jan 5;97(1):71.

PMID:
15572758
[PubMed - indexed for MEDLINE]
Free Article
18.

Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer.

Swain SM, Wilson JW, Mamounas EP, Bryant J, Wickerham DL, Fisher B, Paik S, Wolmark N.

J Natl Cancer Inst. 2004 Apr 7;96(7):516-23.

PMID:
15069113
[PubMed - indexed for MEDLINE]
Free Article
19.

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin WM, Vogel V, Robidoux A, Dimitrov N, Atkins J, Daly M, Wieand S, Tan-Chiu E, Ford L, Wolmark N.

J Natl Cancer Inst. 1998 Sep 16;90(18):1371-88.

PMID:
9747868
[PubMed - indexed for MEDLINE]
Free Article
20.

A prospective study of the development of breast cancer in 16,692 women with benign breast disease.

Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR.

Am J Epidemiol. 1988 Sep;128(3):467-77.

PMID:
3414655
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk